GS vs XTNT · P/E 20, $324.25B cap vs rev $133.9M
Goldman Sachs Group Inc (GS) versus Xtant Medical Holdings Inc (XTNT) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.
GS does not have a complete income-statement cache yet.
Latest reported XTNT revenue for 2025-12-31 was $133.9M. Net income was $5.0M. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. XTNT currently screens at market cap $91.0M.
GS currently screens at market cap $324.25B and trailing P/E 20.1. XTNT currently screens at market cap $91.0M.
Not investment advice. Open the GS and XTNT stock pages for the full models.
Not investment advice.